Fig. 6
From: Transcription factor BACH1 in cancer: roles, mechanisms, and prospects for targeted therapy
Analysis of the correlation between BACH1 and tumor-infiltrating immune cells in various cancers. Correlation between BACH1 and the abundance of multiple infiltrating immune cells in various cancers using TIMER 2.0 database. The purity-corrected partial Spearman’s rho values are displayed with statistical significance (p<0.05) marked with solid squares. ACC: Adrenocortical Carcinoma; BLCA: Bladder Cancer; BRCA: Breast Cancer; CESC: Cervical Cancer; CHOL: Cholangiocarcinoma; COAD: Colon Adenocarcinoma; DLBC: Large B-cell Lymphoma; ESCA: Esophageal Cancer; GBM: Glioblastoma; HNSC: Head and Neck Cancer; KICH: Kidney Chromophobe; KIRC: Kidney Clear Cell Carcinoma; KIRP: Kidney Papillary Renal Cell Carcinoma; LGG: Lower Grade Glioma; LIHC: Hepatocellular Carcinoma; LUAD: Lung Adenocarcinoma; LUSC: Lung Squamous Cell Carcinoma; MESO: Mesothelioma; OV: Ovarian Cancer; PAAD: Pancreatic Adenocarcinoma; PCPG: Pheochromocytoma and Paraganglioma; PRAD: Prostate Adenocarcinoma; READ: Rectal Adenocarcinoma; SARC: Sarcoma; SKCM: Skin Cutaneous Melanoma; STAD: Stomach Adenocarcinoma; TGCT: Testicular Cancer; THCA: Thyroid Carcinoma; THYM: Thymoma; UCEC: Endometrioid Cancer; UCS: Uterine Carcinosarcoma; UVM: Ocular melanoma